Skip to content
Disclosery

EXANE DERIVATIVES: BOTZ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on BOTZ, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 6,310 BOTZ shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 6,310 shares
    Change vs previous 13F 0 shares

    0.07% of the 13F portfolio, value $128,193.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 6,310 shares
    Change vs previous 13F +6,298 shares

    0.05% of the 13F portfolio, value $183,042.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 12 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $431.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 12 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $439.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 12 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $415.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 12 shares
    Change vs previous 13F -214 shares

    <0.01% of the 13F portfolio, value $398.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 226 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $7,488.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 226 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $6,298.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).